INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
BJ

Bitterman Robert J

Director, Chairman, Pres. & CEOCIK 0001304395

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells3 / 0
Max Insider Score35
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
BJ
Bitterman Robert JDirector, Chairman, Pres. & CEO
PHIOPhio Pharmaceuticals Corp.
Grant or award
A—
400.0K sh
Sep 28, 2026Sep 29, 2026
traded Sep 28, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Phio Pharmaceuticals Corp.Director, Chairman, Pres. & CEO · Dec 29, 2025
35
BJ
Bitterman Robert JDirector, Chairman, Pres. & CEO
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY
$2,058
2,000 sh
Sep 22, 2026
Sep 23, 2026
traded Sep 22, 2026
+1d
SEC FORM 4

Evidence

25
BJ
Bitterman Robert JDirector, Chairman, Pres. & CEO
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$9,900
10.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC FORM 4

Evidence

35
BJ
Bitterman Robert JDirector, Chairman, Pres. & CEO
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$5,100
5,000 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC FORM 4

Evidence